Genzyme parent wins OK for MS drug
Linkedin

Genzyme parent wins OK for MS drug

Paris : France | Sep 12, 2012 at 4:37 PM PDT
Source: Boston Globe
XX XX
Views: Pending
 
Sept. 12 (Bloomberg)Sanofi won U.S. clearance for its multiple sclerosis treatment Aubagio, enabling the French drugmaker to enter a $12 billion industry. The Food and Drug Administration approved Aubagio, a once- a-day pill for the debilitating disease, the agency said today in a statement. FULL ARTICLE AT Boston Globe
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

News Stories

 
  • Sanofi multiple sclerosis pill gets US approval

    Fox News
    The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favor among newly diagnosed patients. Around 35 percent to 40 percent of multiple sclerosis (MS) sufferers prefer to take no...
  • Sanofi multiple sclerosis pill gets U.S. approval

    Reuters
    Topics Sanofi CEO Christopher Viehbacher addresses the Boston College's Chief Executives Club of Boston in Massachusetts March 6, 2012. French drugmaker Sanofi SA gained U.S. approval for its multiple sclerosis pill, Aubagio, on Wednesday -- one of...
  • FDA approves Genzyme Corp.'s pill for treating multiple sclerosis

    Boston Globe
    The positive ruling for the Cambridge biotechnology company's therapy, called Aubagio, marks the Food and Drug Administration's first approval of a Genzyme drug since French pharmaceutical giant Sanofi SA bought Genzyme for $20.1 billion in 2010.

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.